Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease ; volume:9 ; number:1 ; day:30 ; month:10 ; year:2023 ; pages:1-11 ; date:12.2023
npj Parkinson's Disease ; 9, Heft 1 (30.10.2023), 1-11, 12.2023
- Creator
-
Diaw, Sokhna Haissatou
Borsche, Max
Streubel-Gallasch, Linn
Dulovic-Mahlow, Marija
Hermes, Julia
Lenz, Insa
Seibler, Philip
Klein, Christine
Brüggemann, Norbert
Vos, Melissa
Lohmann, Katja
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41531-023-00584-z
- URN
-
urn:nbn:de:101:1-2024011708362395981447
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Diaw, Sokhna Haissatou
- Borsche, Max
- Streubel-Gallasch, Linn
- Dulovic-Mahlow, Marija
- Hermes, Julia
- Lenz, Insa
- Seibler, Philip
- Klein, Christine
- Brüggemann, Norbert
- Vos, Melissa
- Lohmann, Katja
- SpringerLink (Online service)
Other Objects (12)
Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients
Models of α-synuclein aggregation in Parkinson’s disease
α-Synuclein in parkinson's disease: pathogenic function and translation into animal models
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson’s disease
Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
Retinal α-synuclein deposits in Parkinson’s disease patients and animal models
Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity
Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients
Models of α-synuclein aggregation in Parkinson’s disease
α-Synuclein in parkinson's disease: pathogenic function and translation into animal models
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson’s disease
Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
Retinal α-synuclein deposits in Parkinson’s disease patients and animal models
Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity
Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients
Models of α-synuclein aggregation in Parkinson’s disease
α-Synuclein in parkinson's disease: pathogenic function and translation into animal models
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Adenosine A1 receptor ligands bind to α-synuclein: implications for α-synuclein misfolding and α-synucleinopathy in Parkinson’s disease
Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
Retinal α-synuclein deposits in Parkinson’s disease patients and animal models